These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 28530513)

  • 1. A cluster randomized trial of strategies to increase uptake amongst young women invited for their first cervical screen: The STRATEGIC trial.
    Kitchener H; Gittins M; Cruickshank M; Moseley C; Fletcher S; Albrow R; Gray A; Brabin L; Torgerson D; Crosbie EJ; Sargent A; Roberts C
    J Med Screen; 2018 Jun; 25(2):88-98. PubMed ID: 28530513
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A cluster randomised trial of strategies to increase cervical screening uptake at first invitation (STRATEGIC).
    Kitchener HC; Gittins M; Rivero-Arias O; Tsiachristas A; Cruickshank M; Gray A; Brabin L; Torgerson D; Crosbie EJ; Sargent A; Roberts C
    Health Technol Assess; 2016 Sep; 20(68):1-138. PubMed ID: 27632816
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cost-effectiveness of strategies to increase cervical screening uptake at first invitation (STRATEGIC).
    Tsiachristas A; Gittins M; Kitchener H; Gray A
    J Med Screen; 2018 Jun; 25(2):99-109. PubMed ID: 28530515
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of Mailed Human Papillomavirus Test Kits vs Usual Care Reminders on Cervical Cancer Screening Uptake, Precancer Detection, and Treatment: A Randomized Clinical Trial.
    Winer RL; Lin J; Tiro JA; Miglioretti DL; Beatty T; Gao H; Kimbel K; Thayer C; Buist DSM
    JAMA Netw Open; 2019 Nov; 2(11):e1914729. PubMed ID: 31693128
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Participation in interventions and recommended follow-up for non-attendees in cervical cancer screening -taking the women's own preferred test method into account-A Swedish randomised controlled trial.
    Lilliecreutz C; Karlsson H; Spetz Holm AC
    PLoS One; 2020; 15(7):e0235202. PubMed ID: 32614875
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluating a community-based cervical cancer screening strategy in Western Kenya: a descriptive study.
    Swanson M; Ibrahim S; Blat C; Oketch S; Olwanda E; Maloba M; Huchko MJ
    BMC Womens Health; 2018 Jul; 18(1):116. PubMed ID: 29970063
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A primary healthcare-based intervention to improve a Danish cervical cancer screening programme: a cluster randomised controlled trial.
    Jensen H; Svanholm H; Støvring H; Bro F
    J Epidemiol Community Health; 2009 Jul; 63(7):510-5. PubMed ID: 19228681
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Vaccine and Cervical Cancer Screen project 2 (VACCS 2): Linking cervical cancer screening to a two-dose HPV vaccination schedule in the South-West District of Tshwane, Gauteng, South Africa.
    Snyman LC; Dreyer G; Visser C; Botha MH; van der Merwe FH
    S Afr Med J; 2015 Mar; 105(3):191-4. PubMed ID: 26294825
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Uptake of Cervical Cancer Screening in Ethiopia by Self-Sampling HPV DNA Compared to Visual Inspection with Acetic Acid: A Cluster Randomized Trial.
    Gizaw M; Teka B; Ruddies F; Abebe T; Kaufmann AM; Worku A; Wienke A; Jemal A; Addissie A; Kantelhardt EJ
    Cancer Prev Res (Phila); 2019 Sep; 12(9):609-616. PubMed ID: 31337647
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Randomized Intervention of Self-Collected Sampling for Human Papillomavirus Testing in Under-Screened Rural Women: Uptake of Screening and Acceptability.
    Racey CS; Gesink DC; Burchell AN; Trivers S; Wong T; Rebbapragada A
    J Womens Health (Larchmt); 2016 May; 25(5):489-97. PubMed ID: 26598955
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Offering self-sampling to cervical screening non-attenders in primary care.
    Lim AW; Hollingworth A; Kalwij S; Curran G; Sasieni P
    J Med Screen; 2017 Mar; 24(1):43-49. PubMed ID: 27235844
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Attendance rate in the Polish Cervical Cancer Screening Program in the years 2007-2009].
    Spaczyński M; Karowicz-Bilinska A; Rokita W; Molińska-Glura M; Januszek-Michalecka L; Seroczyński P; Uchlik J; Nowak-Markwitz E
    Ginekol Pol; 2010 Sep; 81(9):655-63. PubMed ID: 20973201
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluating the effectiveness of cervical cancer screening invitation letters.
    Decker KM; Turner D; Demers AA; Martens PJ; Lambert P; Chateau D
    J Womens Health (Larchmt); 2013 Aug; 22(8):687-93. PubMed ID: 23915107
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Self-sampling for cervical screening offered at the point of invitation: A cross-sectional study of preferences in England.
    Drysdale H; Marlow LA; Lim A; Sasieni P; Waller J
    J Med Screen; 2022 Sep; 29(3):194-202. PubMed ID: 35389282
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Does mailing unsolicited HPV self-sampling kits to women overdue for cervical cancer screening impact uptake of other preventive health services in a United States integrated delivery system?
    Kariya H; Buist DSM; Anderson ML; Lin J; Gao H; Ko LK; Winer RL
    Prev Med; 2022 Jan; 154():106896. PubMed ID: 34800474
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Increasing participation in cervical screening by targeting long-term nonattenders: Randomized health services study.
    Elfström KM; Sundström K; Andersson S; Bzhalava Z; Carlsten Thor A; Gzoul Z; Öhman D; Lamin H; Eklund C; Dillner J; Törnberg S
    Int J Cancer; 2019 Dec; 145(11):3033-3039. PubMed ID: 31032904
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Modeling the impact of screening policy and screening compliance on incidence and mortality of cervical cancer in the post-HPV vaccination era.
    de Blasio BF; Neilson AR; Klemp M; Skjeldestad FE
    J Public Health (Oxf); 2012 Dec; 34(4):539-47. PubMed ID: 22707556
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Increasing participation in cervical cancer screening: offering a HPV self-test to long-term non-attendees as part of RACOMIP, a Swedish randomized controlled trial.
    Broberg G; Gyrd-Hansen D; Miao Jonasson J; Ryd ML; Holtenman M; Milsom I; Strander B
    Int J Cancer; 2014 May; 134(9):2223-30. PubMed ID: 24127304
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Reactions of women underscreened for cervical cancer who received unsolicited human papillomavirus self-sampling kits.
    Malone C; Tiro JA; Buist DS; Beatty T; Lin J; Kimbel K; Gao H; Thayer C; Miglioretti DL; Winer RL
    J Med Screen; 2020 Sep; 27(3):146-156. PubMed ID: 31744374
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Assessing the impact of mailing self-sampling kits for human papillomavirus testing to unscreened non-responder women in Manitoba.
    Jalili F; O'Conaill C; Templeton K; Lotocki R; Fischer G; Manning L; Cormier K; Decker K
    Curr Oncol; 2019 Jun; 26(3):167-172. PubMed ID: 31285661
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.